Correa Andres F, Yankey Hilary, Li Tianyu, Joshi Shreyas S, Kutikov Alexander, Chen David Y, Viterbo Rosalia, Greenberg Richard E, Smaldone Marc C, Uzzo Robert G
Department of Surgical Oncology, Division of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PA.
Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
Urology. 2019 Jan;123:174-180. doi: 10.1016/j.urology.2018.08.044. Epub 2018 Oct 6.
To perform a comprehensive histopathologic review of sporadic resected solitary cT1 renal masses comparing those with and without radiographic involvement of the hilum.
A prospectively maintained database was queried for all cT1 renal masses undergoing resection classified per the R.E.N.A.L. nephrometry score. Hilar masses were defined as tumors that abut the main renal artery or vein on cross-sectional imaging. Demographic, treatment, renal mass, and histopathologic characteristics were compared between hilar and nonhilar renal masses. Multivariate regression model analyses were performed to assess factors associated with renal mass upstaging and disease recurrence.
A total of 1324 stage 1 renal masses met criteria for analysis of which 226 (17.1%) were defined as hilar. Hilar masses were larger, scored with higher complexity, and more likely to undergo a radical nephrectomy. On histopathologic analysis, we found no difference between hilar and nonhilar masses regarding the incidence of malignancy, presence of high nuclear grade, or risk of upstaging. On multivariate analysis, a tumor's hilar location was not associated with upstaging or disease recurrence.
We present a comprehensive histopathologic review of a large cohort of cT1 hilar lesions noting no difference in the risk of malignancy, high nuclear grade, upstaging, or recurrence when compared to nonhilar lesions. Together, these data suggest that there is no compelling cancer-specific rationale to perform a radical nephrectomy when managing renal hilar tumors.
对散发性切除的孤立性cT1期肾肿块进行全面的组织病理学回顾,比较肾门有无影像学累及的肿块。
查询前瞻性维护的数据库,获取所有根据R.E.N.A.L.肾计量评分分类的接受切除的cT1期肾肿块。肾门肿块定义为在横断面成像上毗邻肾主动脉或静脉的肿瘤。比较肾门和非肾门肾肿块的人口统计学、治疗、肾肿块及组织病理学特征。进行多变量回归模型分析,以评估与肾肿块分期升级和疾病复发相关的因素。
共有1324例1期肾肿块符合分析标准,其中226例(17.1%)被定义为肾门肿块。肾门肿块更大,复杂性评分更高,更有可能接受根治性肾切除术。组织病理学分析显示,肾门和非肾门肿块在恶性肿瘤发生率、高核分级的存在或分期升级风险方面无差异。多变量分析显示,肿瘤的肾门位置与分期升级或疾病复发无关。
我们对一大组cT1期肾门病变进行了全面的组织病理学回顾,发现与非肾门病变相比,在恶性肿瘤风险、高核分级、分期升级或复发方面无差异。总之,这些数据表明,在处理肾门肿瘤时,没有令人信服的癌症特异性理由进行根治性肾切除术。